Stay informed on RenovoRx's earnings date, reports, and conference call with Futubull. View estimates and historical data for EPS, revenue, and EBIT.
CannaPharmaRx Inc (CPMD) Earnings CPMD 收益日期 CPMD 的收益公告*: undefined我们的供应商 Zacks Investment Research 未向我们提供未来收益报告日期。Latest Press Release CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy Dec 3, 2024 See All Press Releases -> ...
this earnings release also contains non-GAAP financial measures. The reasons why we believe these measures provide useful information to investors and, for historical periods, a reconciliation of these measures to the most directly comparable GAAP measures are included ...
Data ranges from 2023-12-31 00:00:00 to 2024-09-30 00:00:00. The chart has 1 Y axis displaying values. Data ranges from -0.46 to -0.33. -0.46-0.33 End of interactive chart.Earnings Estimates Next Earnings Release Date - 02/25/25 [--] Current Qtr 12/2024 Next Qtr 03/2025 ...
期权链 卖空数量 机构持股 内部活动 向美国证交会 (SEC) 提交的文件 营收每股收益 (EPS) 浏览英文版网站 Symbol Search Screener -> Related Pages Earnings Date-> Trending Stocks Trending ETFs Trending Indexes TradeTalks Sign up for the TradeTalks newsletter to receive your weekly dose of tra...
OptimizeRx Corp (OPRX) Reports Q3 2023 Earnings, Raises 2023 Guidance and Introduces 2024 Guidance (GuruFocus.com)+15.31% 07:00AM OptimizeRx Reports Third Quarter 2023 Financial Results (GlobeNewswire) Oct-30-23 10:00AM OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the St...
SA TranscriptsWed, Feb. 28, 2024 RxSight, Inc. (RXST) Q3 2023 Earnings Call TranscriptSA TranscriptsSun, Nov. 12, 2023 See All Transcripts » Investor Presentations Rxsight (RXST) Investor Presentation - SlideshowThu, Mar. 16, 2023 Rxsight (RXST) Investor Presentation - SlideshowThu, Jan....
Information on stock, financials, earnings, subsidiaries, investors, and executives for OptimizeRx. Use the PitchBook Platform to explore the full profile.
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call SANTA MONICA, Calif. --(BUSINESS WIRE)--Apr. 9, 2025-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S. , today announced it...
52-week range 0.282.59 Market cap 129.23M P/E ratio n/a Next earnings date Apr 30, 2025 Dividend yield n/a Ex-dividend date n/a Dividend pay date n/a Market cap: $129.23M A market capitalization up to $300 million places LXRX in the micro-capitalization category.Smart...